Scope Review of Clinical Trials in the Cannabinoid Drug Industry & Maintaining Momentum
8:30 am - Wednesday 15th October 2025
- Analyzing clinical trials in cannabinoid therapeutics to assess their progress and prospects
- Identifying gaps in research and highlighting promising areas for future clinical investigation
- Supporting strategic planning for Phase III and IV trials to maintain momentum in cannabinoid therapeutic development